HOME >> BIOLOGY >> NEWS
Nearly identical controls of immune genes in mice and humans hint at new asthma treatment

Three potent proteins of the immune system, evolved to purge us of intestinal parasites, now often launch misguided attacks in our airways, triggering the congestion of asthma that leaves millions gasping for air.

By studying the genetic machinery that controls production of these immune soldiers called cytokines, a team of scientists has demonstrated a potential strategy to silence their misfiring and quell the asthma response.

In back-to-back papers in April and May, researchers at UC San Francisco and the Lawrence Berkeley National Laboratory (LBL) report that a stretch of DNA controlling all three cytokine genes is so similar in humans and mice that the mouse DNA can activate the three human genes inserted in a mouse.

The researchers showed too that the activity of all three genes can be at least partially blocked, suggesting that a single drug could be used to attack asthma at its genetic source. Such a drug could be reliably tested in mice, their study shows.

"The primary aim of our research has been to demonstrate that if non-coding regions of DNA (stretches containing no genes) have been conserved in species separated by many millions of years, they probably perform vital functions," said Richard Locksley, MD, investigator in the Howard Hughes Medical Institute and professor of medicine and microbiology/ immunology at UCSF.

"But in choosing a DNA region that modulates the genes for the cytokines IL-4, 5 and 13, we are dealing with genes that are dramatically expressed in asthma and other allergic diseases. Our experiments show that all three genes are regulated by the same non-coding DNA region, and interruption of this control affects all three genes at once. By blocking the activity of this region, we should be able to block the expression of all three genes."

Many drugs are now being designed to interfere with activity of a single gene or the protein coded by that gene, but developing a drug to treat a disease caused b
'"/>

Contact: Wallace Ravven
wravven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
19-Apr-2000


Page: 1 2 3 4

Related biology news :

1. Nearly two-thirds of GPs are unaware that insulin resistance, a fundamental cause of type 2 diabetes, is thought to be present in 92% of people with the disease
2. Nearly half of all women 65 and older now use herbal products to feel better, but dont tell their doctors
3. Nearly half of Earths land has been transformed by humans; 50 dead zones found in oceans
4. Honeybees In The Wild Nearly Gone In North America
5. Coexistence of identical competitors: an old doctrine challenged
6. Close communication between identical twins helps them live longer
7. Genes, neurons, and the Internet found to have some identical organizing principles
8. Cattle, human genomes contain many identical genes
9. NIAAA-led study verifies environment-dependent behavioral variation in genetically identical mice
10. Protein controls acid in cells by direct detection of volume changes, study finds
11. Biologists discover nerve activity, not just genetics controls kinds of neurotransmitters produced

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 24, 2020 , ... ... treatment of chronic inflammatory and fibrotic diseases, today announced that Dr. Stacie Canan ... Drug Discovery. , Dr. Canan previously served as Executive Director of Global Health ...
(Date:8/26/2020)... ... August 25, 2020 , ... Catalent, the leading global ... and gene therapies, and consumer health products, today announced that two Catalent Biologics ... Expo, taking place between Aug. 31 – September 4, 2020. , On Wednesday, ...
(Date:8/23/2020)... ... August 21, 2020 , ... ... has been published and is now available on the company’s global website. ... the X-ray analysis community, presenting current news and crystallographic research. , The ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 30, 2020 , ... ... software for the life sciences industry, today announced the release of its ... specifically for Medical Science Liaisons (MSLs) and other field medical professionals. ...
(Date:7/18/2020)... ... 2020 , ... Medial EarlySign , a leader in ... high-burden diseases, and Centric Consulting, a business and technology consulting firm, today announced ... in order to identify and prioritize patients for care. , Combining Centric’s management ...
(Date:7/10/2020)... KONG (PRWEB) , ... July 09, 2020 , ... ... compound called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in zebrafish ... the PolyU research team led by Dr MA has been using the zebrafish ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... growth of 40% in 2020, despite many obstacles created as a result of ... increase revenue for its partnered medical practices and medical manufacturers by expanding access ...
Breaking Biology Technology:
Cached News: